EyeGate Pharmaceuticals Inc (EYEG) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for EyeGate Pharmaceuticals Inc (EYEG:NASDAQ), powered by AI.
- Current Price
- $35.27
- P/E Ratio
- -19.9
- Market Cap
- 161M
- Sector
- Unknown
What is the EyeGate Pharmaceuticals Inc stock price forecast?
EyeGate Pharmaceuticals Inc is currently trading at $35.27. View real-time AI analysis on Alpha Lenz.
What is EyeGate Pharmaceuticals Inc insider trading activity?
View the latest insider trading data for EyeGate Pharmaceuticals Inc on Alpha Lenz.
What is EyeGate Pharmaceuticals Inc's P/E ratio?
EyeGate Pharmaceuticals Inc's P/E ratio is -19.9.
EyeGate Pharmaceuticals Inc
NASDAQ · EYEG“EyeGate Pharmaceuticals Inc trades at a P/E of -19.9 (undervalued) with modest ROE of 7.8%.”
Ask for details →Company Overview
The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest.
Company Statistics
FY 2020Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“EyeGate Pharmaceuticals Inc trades at a P/E of -19.9 (undervalued) with modest ROE of 7.8%.”
Ask for details →Frequently Asked Questions
EyeGate Pharmaceuticals Inc (ticker: EYEG) is a company listed on NASDAQ in the Unknown sector (Unknown). Market cap is $161M.
The current price is $35.271 with a P/E ratio of -19.95x and P/B of -1.49x.
ROE is 7.77% and operating margin is -68104.78%. Annual revenue is $12,059.